Therefore, the inhibition of tumor proliferation by PPARγactivators may be explained in part by PPARγ-dependent TGFβ1 repression(Figure 2), supporting the concept that the PPARγ activators may be applied forcontrolling TGFβ1-induced cancer metastasis and fibrosis. The gene discussed is TGFB1; the disease is cancer.